Predictive Oncology Stock Price Prediction

Intrinsic Valuation Low Real High 0.04 0.75 4.36 Details

Naive Forecast Low Next High 0.02 0.84 4.45 Details

1 Analysts Consensus Low Target High 2.73 3.00 3.33 Details

Please note, it is not enough to conduct a financial or market analysis of a single entity such as Predictive Oncology. Your research has to be compared to or analyzed against Predictive Oncology's peers to derive any actionable benefits. When done correctly, Predictive Oncology's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Predictive Oncology.

Predictive Oncology After-Hype Price Prediction Density Analysis

Predictive Oncology Estimiated After-Hype Price Volatility

Predictive Oncology Stock Price Prediction Analysis

Expected Return	Period Volatility	Hype Elasticity	Related Elasticity	News Density	Related Density	Expected Hype
0.40	3.64	0.00	0.37	11 Events / Month	5 Events / Month	In about 11 days

Latest traded price	Expected after-news price	Potential return on next major news	Average after-hype volatility
0.80	0.80	0.00	36,400   Notes

Predictive Oncology Hype Timeline

Predictive Oncology is at this time traded for 0.80. The entity stock is not elastic to its hype. The average elasticity to hype of competition is -0.37. Predictive is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is at this time at -0.4%. %. The volatility of related hype on Predictive Oncology is about 391.4%, with the expected price after the next announcement by competition of 0.43. The company has price-to-book ratio of 1.43. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Predictive Oncology recorded a loss per share of 1.43. The entity last dividend was issued on the 29th of October 2019. The firm had 1:20 split on the 24th of April 2023. Given the investment horizon of 90 days the next forecasted press release will be in about 11 days. Check out Predictive Oncology Basic Forecasting Models to cross-verify your projections. For more detail on how to invest in Predictive Stock please use our How to Invest in Predictive Oncology guide.

Predictive Oncology Related Hype Analysis

Predictive Oncology Additional Predictive Modules

Most predictive techniques to examine Predictive price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Predictive using various technical indicators. When you analyze Predictive charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

The successful prediction of Predictive Oncology stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Predictive Oncology, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Predictive Oncology based on analysis of Predictive Oncology hews, social hype, general headline patterns, and widely used predictive technical indicators.

The number of cover stories for Predictive Oncology depends on current market conditions and Predictive Oncology's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Predictive Oncology is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Predictive Oncology's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Predictive Oncology's future price predictability will typically decrease when Predictive Oncology's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Predictive Oncology often depends not only on the future outlook of the potential Predictive Oncology's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Predictive Oncology's indicators that are reflective of the short sentiment are summarized in the table below.

When running Predictive Oncology's price analysis, check to measure Predictive Oncology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Predictive Oncology is operating at the current time. Most of Predictive Oncology's value examination focuses on studying past and present price action to predict the probability of Predictive Oncology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Predictive Oncology's price. Additionally, you may evaluate how the addition of Predictive Oncology to your portfolios can decrease your overall portfolio volatility.